CRMG is an actively managed, single-stock leveraged ETF that seeks daily investment results equal to 200% of the daily percentage change in the common stock of Salesforce (NYSE: CRM), before fees and expenses. Rather than holding Salesforce shares directly, the fund pursues its objective through a small portfolio of swap agreements with major financial institutions, with Treasury money-market instruments held as collateral. The fund carries a total expense ratio of approximately 0.75% and is non-diversified.
This structure makes CRMG effectively a leveraged expression of a single company's stock. Its exposure is not a broad basket of industries but nearly 100% synthetic exposure to Salesforce, so the ETF's recent performance is almost entirely a function of one name. For investors, that concentration amplifies both gains and losses and introduces daily-reset compounding effects that can cause multi-day returns to deviate from twice the underlying's move.
Over the trailing 30 days, CRMG rose approximately +58%, from a close near $5.94 to about $9.39. The advance was not gradual: most of the gain arrived in a single, gap-up session after the company's fiscal second-quarter report, when the fund jumped roughly 44% in one day as Salesforce shares surged about 22.6%. The move was trend-driven and volatile rather than range-bound.
Looking at the trailing quarter, CRMG has climbed roughly +91% from a level near $4.92 three months earlier. The path was uneven. The fund entered the period near $7.48, slid to a trough around $3.78 by mid-June during a broad enterprise-software selloff, and then staged a powerful recovery that accelerated sharply after the August earnings report.
The dominant catalyst was Salesforce's fiscal second-quarter report, which reset sentiment across the enterprise-software complex. The company reported adjusted earnings per share (EPS) of $5.90, far above the $3.27 consensus, on revenue of $11.35 billion, up 11% year over year. Free cash flow rose 81% to $1.1 billion, and management raised full-year adjusted EPS guidance to roughly $16.67–$16.71 from about $14.06–$14.12. The EPS figure included a gain tied to Salesforce's stake in Anthropic, though the jump in free cash flow pointed to genuine operating momentum.
The AI narrative drove the reaction. Agentforce, Salesforce's agentic AI platform, reached $1.5 billion in annual recurring revenue (ARR), up 240% year over year, while the Data 360 platform's ARR roughly tripled. Salesforce also announced "Claudeforce," an expanded partnership with Anthropic to integrate Claude's reasoning into Salesforce workflows. These results countered earlier fears that generative AI would undermine software demand, and Salesforce stock jumped about 22.6% in a single session. With its 2x daily leverage, CRMG amplified that move into a roughly 44% single-day gain.
The broader three-month trend reflects a sharp rotation in enterprise software. During the first half of the year, Salesforce and many software peers sold off on fears that AI agents would reduce demand for traditional seat-based software — a narrative sometimes described as the "SaaS apocalypse." Salesforce fell sharply through June and became one of the weakest large-cap performers, and CRMG, as a leveraged vehicle, declined even more dramatically.
The August earnings report reversed that narrative by demonstrating that AI had become a measurable revenue driver rather than a threat. Combined with short-covering — short interest in Salesforce had built up during the selloff — and renewed institutional buying in software, this powered a multi-week recovery that lifted CRMG far above its June lows.
Tickeron's AI Screener is an AI-powered discovery platform that helps investors scan thousands of stocks and ETFs using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, and AI-generated signals. It is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening. For investors monitoring leveraged and thematic ETFs such as CRMG, the tool can help identify momentum shifts and compare opportunities across sectors. Explore the AI Screener to refine your own watchlist and research workflow.
Going forward, CRMG's path will remain tied to Salesforce and, more broadly, to the enterprise-AI spending cycle. Key factors to monitor include the pace of Agentforce adoption and renewal activity, the rollout of the Claudeforce integration, and whether Salesforce can sustain double-digit revenue growth and margin expansion in upcoming quarters. Macroeconomic conditions — interest-rate expectations, inflation, and corporate IT budgets — will also influence the software sector's valuation multiple.
Investors should also account for the structural risks of a leveraged single-stock ETF. Daily rebalancing can produce compounding losses in choppy markets, and a decline in the underlying security could result in outsized losses. The next Salesforce earnings report, updates to full-year guidance, and broader software-sector sentiment will be the most important near-term catalysts for CRMG.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Oscillator for CRMG moved out of overbought territory on September 08, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 instances where the indicator moved out of the overbought zone. In 5 of the 5 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 12 of 13 cases where CRMG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on September 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRMG as a result. In 21 of 21 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CRMG turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 10 similar instances when the indicator turned negative. In 10 of the 10 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRMG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
CRMG broke above its upper Bollinger Band on August 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Following a +1.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRMG advanced for three days, in 64 of 76 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 21 of 28 cases where CRMG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.